Therapy of multiple myeloma and myeloma-related kidney disease

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F17%3A00011898" target="_blank" >RIV/00023736:_____/17:00011898 - isvavai.cz</a>

Result on the web

<a href="http://smjournals.com/nephrology-therapeutics/in-press.php" target="_blank" >http://smjournals.com/nephrology-therapeutics/in-press.php</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Therapy of multiple myeloma and myeloma-related kidney disease

Original language description

Multiple Myeloma (MM) is a clonal expansion of plasma cells. MM is characterized by proliferation of malignant clones producing defective monoclonal immunoglobulins in the bone marrow. MM is the second most common blood cancer following non-Hodgkin´s lymphoma. It remains an incurable disease with resistance to drugs leading to relapse in most patients even if the treatments for MM have improved over the past decade. Therefore, it is necessary to understand the detailed mechanisms of MM pathogenesis and the drug resistance of MM and develop more effective therapeutic strategies.

Czech name

—

Czech description

—

Type

J_ost - Miscellaneous article in a specialist periodical

CEP classification

—

OECD FORD branch

30205 - Hematology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

SM Journal of nephrology and therapeutics

ISSN

2573-3613

e-ISSN

—

Volume of the periodical

1

Issue of the periodical within the volume

1

Country of publishing house

US - UNITED STATES

Number of pages

14

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—